Pt. Novell Pharmaceutical Laboratories is a finished-dose manufacturer based in Indonesia. It appears in 69 regulatory filings across 4 regulators, without an active US DMF or CEP on file. Its filings concentrate with DAV (Vietnam), NPRA (MY) and EDE (AE). Its GMP standing is certified by BPOM (ID) and EMA. Customs aggregates show $2.8M of exports covering 157 molecules to 23 destinations in 2025.
| Site | FDA FEI |
|---|---|
| Bogor, United Arab Emirates | Not on file |
| Bogor, United Arab Emirates | Not on file |
| Gunung Putri, Indonesia | Not on file |
| Regulator | Filings | GMP certificates |
|---|---|---|
| DAV (Vietnam) | 50 | None |
| NPRA (MY) | 11 | None |
| EDE (AE) | 5 | None |
| SFDA (Saudi Arabia) | 3 | None |
| BPOM (ID) | None | 42 |
| EMA | None | 3 |
| Year | Revenue | Exports | Destinations |
|---|---|---|---|
| 2025 | Not reported | $2.8M | 23 |
| 2024 | Not reported | $6.1M | 28 |
Export figures are customs aggregates. We do not publish the identity of any buyer.
Answered from this company's own record. Where a register holds nothing, the question is not asked rather than answered with a zero. How we count our figures.
Choose your molecules and target markets. Pt. Novell Pharmaceutical Laboratories comes back tiered against every other supplier able to file there.
Start for freeRanked by shared active ingredients where we have them, otherwise by country and comparable credentials.